-Biotechnology Transactional Advisor

With over 30 years experience in leading biopharma business transactions (collectively $1B+), he specializes in working with small biotech in external business development roles.

-Clinical Researcher

-FTD Advisor, Psilera

Dr. Finger is the leading expert in behavioral neurology associated with frontotemporal dementia (FTD). She is currently running a phase II study in FTD with intranasal oxytocin.

-Assistant Professor, University of Wisconsin School of Medicine and Public Health

-Clinical Development Advisor, Psilera

Clinical psychologist and research scientist focused on investigating the therapeutic application and mechanisms of psychedelics (psilocybin; DMT, 5-MeO-DMT, MDMA) and novel compounds for mental health, addiction, and chronic pain.

-Founder, Hoberman Law Group PLLC

-Legal Advisor, Psilera

Lori specializes in advising entrepreneurs and their investors on how to build successful businesses and strategically guides them through the emerging, later stages and exits of their companies.

-Vice President Strategic Planning, Bristol-Myers Squibb

Anthony is a Harvard and Cornell graduate with over 30 years of experience. He provides perspective and context for our asset and ROI valuation process.

-Chairman & CEO, BalinBac Therapeutics, Inc.

-Non-executive Director, Psilera

Over 33 years of experience in pharmaceutical industry. Focused areas of expertise: Medical Devices, Biotechnology, Market Research, Endocrinology, and Healthcare.

-Patent Advisors, Psilera

DN&Z has been providing legal services and solutions to corporations, entrepreneurs, growing businesses and successful companies for over 30 years in the areas of litigation, corporate law, labor and employment law, intellectual property, life sciences, cybersecurity and data privacy.

-Scientific and Regulatory Experts

-Regulatory Advisors, Psilera

Facet leverages strong scientific, development, and regulatory expertise to help small organizations bring great science and innovative products to and through the FDA.

- Collaborators since 2025

- Developers of organ-on-a-chip technology being used to study disease mechanisms and drug efficacy in the preclinical stages of PSIL-006.

-Assistant Professor, University of Wisconsin Maddison

-Director of Psychoactive Pharmaceutical Investigation

-Research collaborator since 2021

Pursues the development and application of chemical and biological tools that can uncover shared molecular deficits in stress management and reward function.

-Staff Scientist at The National Institute on Drug Abuse (NIDA)

-Scientific Advisor since 2020

33 years of dedication to the advancement of knowledge tied to addictions and their treatments.

-Postdoctoral Researcher, University of South Florida

-Scientific collaborator since 2019

Steven’s passionate research into computational chemistry platforms has honed the development of our own drug development platform: Psilera Third Eye.

-Assistant Professor at Medical College of Wisconsin

-Scientific collaborator since 2020

Over 13 years of experience in academic research specializing in the understanding of psychedelic compounds.

-Associate Professor & Researcher at University of South Florida

-Scientific collaborator since 2021

Dani provides invaluable insights into small mammal behavior testing and data interpretation.

-Collaborators since 2020

In coordination with the National Institute of Health, NIDA and Psilera have joined forces to better understand the therapeutic potential of re-purposed psychedelic compounds.